<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03170830</url>
  </required_header>
  <id_info>
    <org_study_id>KYZ2017001</org_study_id>
    <nct_id>NCT03170830</nct_id>
  </id_info>
  <brief_title>Diagnostic Value of CircRNA-Uck2 for Acute Myocardial Infarction</brief_title>
  <official_title>Study on CircRNA-Uck2 as a New Diagnostic Marker of Acute Myocardial Infarction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Beijing Haidian Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Beijing Fangshan District Liangxiang Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Beijing Haidian Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is an observational diagnostic study that aims to evaluate the diagnostic value of
      circRNA-Uck2 in Acute Myocardial Infarction (AMI) in adults as compared to healthy and
      unstable angina controls. Rapid and adequate diagnosis of AMI is of great importance to
      enable a rapid start of treatment, save large tracts of dying myocardium, reduce the infarct
      size,and thereby decrease the risk of subsequent heart failure.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      RATIONAL acute myocardial infarction (AMI) is the leading cause of sudden death and heart
      failure worldwide. And about 10% of all emergency department consultations are with symptoms
      suggestive of AMI, however, only 10% to 20% of them are diagnosed as experiencing an AMI.
      Rapid and accurate identification of AMI is of paramount clinical importance for subsequent
      timely and effectively treatment and management.

      Recently, the investigators identified microarray analysis and real-time polymerase chain
      reaction (PCR) from AMI animal models and small samples of AMI patients, a molecular
      signature of AMI involving 5 circRNAs (circRNA_006877, circRNA_015350, circRNA_002969,
      circRNA_013240, circRNA_004682) was found significantly change in AMI patients and likely
      serves as candidate serum biomarkers of AMI. Among the 5 circRNAs, circRNA_006877 name of
      circRNA-Uck2 (cUck2) has more close association with AMI.

      TYPE OF STUDY : multicenter diagnostic evaluation Study MAIN PURPOSE OF THE STUDY : To
      evaluate the diagnostic value of circRNAs in AMI in adults as compared to healthy and
      unstable angina controls

      SECONDARY OBJECTIVES :

      assess the ability of cUck2 to discriminate a AMI disease from unstable angina patients in
      adults.

      explore the relationship between cUck2 and heart function after myocardial infarction
      PRODUCTS OF THE STUDY diagnostic kit of AMI in quantitative polymerase chain reaction (qPCR)
      NUMBER OF PATIENTS : 3 groups with 169 patients will be included Group 1: 66 AMI adult
      patients Group 2: 56 unstable angina adults Group 3: 56 Witnesses healthy adults INCLUSION
      LENGTH 36 months DURATION OF THE STUDY 42 months
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 1, 2015</start_date>
  <completion_date type="Anticipated">December 31, 2018</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Single (Participant)</masking>
    <masking_description>Sample inspector</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>The change of cUck2 levels in AMI</measure>
    <time_frame>It is totally 7 time points to detect cUck2, including the moment of admission, and the 1st day、the 2nd day、the 3th day、the 7th day、the 14th day、the 6th month after admission in AMI patients.</time_frame>
    <description>The investigators has found cUck2 has more close association with AMI.Detect cUck2 levels in different time points and it will give more information about its diagnostic value in AMI.</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">178</enrollment>
  <condition>Cardiac Disease</condition>
  <condition>Diagnoses Disease</condition>
  <condition>Acute Myocardial Infarction</condition>
  <arm_group>
    <arm_group_label>Healthy control group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Age:45-75 years.Pepole who have normal ECG without the history of cardiovascular disease can be included in the healthy control group.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>unstable angina disease control group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Age:&gt;18 years.Unstable angina patients meet the diagnostic criteria.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>acute myocardial infarction group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Age:&gt;18 years.Acute myocardial infarction patients meet the diagnostic criteria.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>the diagnosis value of cUck2 in acute myocardial infarction.</intervention_name>
    <description>Collect blood at different time points and compare cUck2 in three groups.</description>
    <arm_group_label>Healthy control group</arm_group_label>
    <arm_group_label>unstable angina disease control group</arm_group_label>
    <arm_group_label>acute myocardial infarction group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Health Control Group:Pepole who have normal ECG, deny the history of cardiovascular
             disease can be included in the healthy control group.

          -  Acute Myocardial Infarction Group:Clinical diagnosis of acute myocardial infarction

          -  Unstable Angina Group:Clinical diagnosis of unstable angina.

          -  Sign informed consent.

        Exclusion Criteria:

          -  Myocarditis, hypertrophic cardiomyopathy, ablation.

          -  Malignant hypertension, severe arrhythmia.

          -  Chronic muscle disorders, rhabdomyolysis.

          -  Severe liver and kidney dysfunction.

          -  Malignant tumors, acute cerebrovascular disease.

          -  Severe neurosis, psychosis.

          -  Patients who had any of the above were excluded.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hong-Jin Wu</last_name>
    <role>Study Director</role>
    <affiliation>Beijing Haidian Hospital,Haidian Section of Peking University Third Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Hong-Yun Wang</last_name>
    <phone>+8618810252933</phone>
    <email>wanghongyun5491@163.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jing Li</last_name>
    <phone>+8618810551082</phone>
    <email>zhiyaguniang@sina.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Beijing Haidian Hospital, Haidian Section of Peking University Third Hospital</name>
      <address>
        <city>Beijing</city>
        <state>China/Beijing</state>
        <zip>100080</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hong-Yun Wang</last_name>
      <phone>+8618810252933</phone>
      <email>wanghongyun5491@163.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Danese E, Montagnana M. An historical approach to the diagnostic biomarkers of acute coronary syndrome. Ann Transl Med. 2016 May;4(10):194. doi: 10.21037/atm.2016.05.19. Review.</citation>
    <PMID>27294090</PMID>
  </reference>
  <reference>
    <citation>Sanger HL, Klotz G, Riesner D, Gross HJ, Kleinschmidt AK. Viroids are single-stranded covalently closed circular RNA molecules existing as highly base-paired rod-like structures. Proc Natl Acad Sci U S A. 1976 Nov;73(11):3852-6.</citation>
    <PMID>1069269</PMID>
  </reference>
  <reference>
    <citation>Jeck WR, Sorrentino JA, Wang K, Slevin MK, Burd CE, Liu J, Marzluff WF, Sharpless NE. Circular RNAs are abundant, conserved, and associated with ALU repeats. RNA. 2013 Feb;19(2):141-57. doi: 10.1261/rna.035667.112. Epub 2012 Dec 18. Erratum in: RNA. 2013 Mar;19(3):426.</citation>
    <PMID>23249747</PMID>
  </reference>
  <reference>
    <citation>Suzuki H, Zuo Y, Wang J, Zhang MQ, Malhotra A, Mayeda A. Characterization of RNase R-digested cellular RNA source that consists of lariat and circular RNAs from pre-mRNA splicing. Nucleic Acids Res. 2006 May 8;34(8):e63.</citation>
    <PMID>16682442</PMID>
  </reference>
  <reference>
    <citation>Holdt LM, Stahringer A, Sass K, Pichler G, Kulak NA, Wilfert W, Kohlmaier A, Herbst A, Northoff BH, Nicolaou A, Gäbel G, Beutner F, Scholz M, Thiery J, Musunuru K, Krohn K, Mann M, Teupser D. Circular non-coding RNA ANRIL modulates ribosomal RNA maturation and atherosclerosis in humans. Nat Commun. 2016 Aug 19;7:12429. doi: 10.1038/ncomms12429.</citation>
    <PMID>27539542</PMID>
  </reference>
  <reference>
    <citation>Wang K, Long B, Liu F, Wang JX, Liu CY, Zhao B, Zhou LY, Sun T, Wang M, Yu T, Gong Y, Liu J, Dong YH, Li N, Li PF. A circular RNA protects the heart from pathological hypertrophy and heart failure by targeting miR-223. Eur Heart J. 2016 Sep 1;37(33):2602-11. doi: 10.1093/eurheartj/ehv713. Epub 2016 Jan 21.</citation>
    <PMID>26802132</PMID>
  </reference>
  <reference>
    <citation>Meder B, Keller A, Vogel B, Haas J, Sedaghat-Hamedani F, Kayvanpour E, Just S, Borries A, Rudloff J, Leidinger P, Meese E, Katus HA, Rottbauer W. MicroRNA signatures in total peripheral blood as novel biomarkers for acute myocardial infarction. Basic Res Cardiol. 2011 Jan;106(1):13-23. doi: 10.1007/s00395-010-0123-2. Epub 2010 Oct 1.</citation>
    <PMID>20886220</PMID>
  </reference>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 19, 2017</study_first_submitted>
  <study_first_submitted_qc>May 26, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 31, 2017</study_first_posted>
  <last_update_submitted>May 26, 2017</last_update_submitted>
  <last_update_submitted_qc>May 26, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 31, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Beijing Haidian Hospital</investigator_affiliation>
    <investigator_full_name>Hong-Jin Wu</investigator_full_name>
    <investigator_title>Clinical Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infarction</mesh_term>
    <mesh_term>Myocardial Infarction</mesh_term>
    <mesh_term>Heart Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

